TACR1 and irritable bowel syndrome: Several studies have documented the therapeutic efficacy of different NK1R antagonists in rodent models of nociception17,50, and in patients with irritable bowel syndrome, pain and anxiety was reduced by chronic NK1R antagonist treatment51.